new glp 1 drugs Decoding GLP-1 Weight Loss Medications FDA says that the GLP-1

Expanding healthcare systems in countries such as China and India, along with improved access to advanced therapies, are strengthening demand for effective glucose-lowering and weight-management treatments

But in August, The Washington Post reported the Trump administration was considering a five-year pilot program for Medicare and Medicaid to cover the drugs after all

Some providers explore microdosing GLP-1 for autoimmune conditions , which follows a completely different dosing and timeline protocol than weight management

A ResMed-supported study found that, after one year, there was no significant difference in CPAP adherence or discontinuation rates among recent GLP-1 users with OSA

In a year filled with gridlock for biomedical research and public health, your voice kept ME/CFS on the agenda

JAMA 2022;327:534-45.ArticlePubMedPMC 129